US16941T3023 - Common Stock
CHINA PHARMA HOLDINGS INC
NYSEARCA:CPHI (5/3/2024, 7:04:03 PM)
After market: 0.3148 0 (-1.1%)0.3183
+0.01 (+4.88%)
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 234 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
CHINA PHARMA HOLDINGS INC
2nd Floor, No. 17, Jinpan Road, Haikou
Haikou HAINAN 570216
P: 8689866811730
CEO: Zhilin Li
Employees: 234
Website: http://www.chinapharmaholdings.com
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Get insights into the top gainers and losers of Wednesday's after-hours session.
China Pharma Holding just reported results for the fourth quarter of 2023.
China Pharma Holdings (CPHI) plans to implement a 1-for-5 reverse stock split, causing shares to rise in extended trading.
China Pharma filed a prospectus for a mixed shelf offering to raise up to $500M; the prospectus is not an offer to sell securities.
The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!
Here you can normally see the latest stock twits on CPHI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: